Progyny: Peter Anevski plans $9.47M share sale
The notice says shares were and will be received through stock-option exercises over the next three months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Progyny, Inc. (PGNY) is named in a notice for a planned sale of 314,738 common shares for Peter Anevski’s account, with an aggregate market value of $9,473,613.80. Morgan Stanley Smith Barney LLC is listed as broker.
Key Figures
Key Terms
Rule 144 regulatory
stock options financial
securities to be sold regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.